Symbols / CRMD Stock $7.55 -4.79% CorMedix Inc.

Healthcare • Biotechnology • United States • NGM
CRMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Joseph Todisco MBA
Exch · Country NGM · United States
Market Cap 592.24M
Enterprise Value —
Income 180.02M
Sales 400.05M
FCF (ttm) —
Book/sh 5.11
Cash/sh —
Employees 191
Insider 10d —
IPO May 13, 2010
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 3.70
Forward P/E 10.41
PEG —
P/S 1.48
P/B 1.48
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq 36.74
LT Debt/Eq —
EPS (ttm) 2.04
EPS next Y 0.72
EPS Growth 43.30%
Revenue Growth 226.10%
EPS Gr Q/Q 87.00%
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-14
ROA —
ROE —
ROIC —
Gross Margin 91.86%
Oper. Margin 49.96%
Profit Margin 45.25%
Shs Outstand 78.44M
Shs Float 68.04M
Insider Own 7.51%
Instit Own 56.95%
Short Float 20.96%
Short Ratio 16.03
Short Interest 16.22M
52W High 17.43
vs 52W High -56.68%
52W Low 6.13
vs 52W Low 23.16%
Beta —
Impl. Vol. 49.05%
Rel Volume 2.16
Avg Volume 1.31M
Volume 2.83M
Target (mean) $15.14
Tgt Median $15.00
Tgt Low $13.00
Tgt High $19.00
# Analysts 7
Recom Strong_buy
Prev Close $7.93
Price $7.55
Change -4.79%
About

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.14
Mean price target
2. Current target
$7.55
Latest analyst target
3. DCF / Fair value
$30.60
Fallback: EPS × 15 (assumed fair P/E). No FCF data; use with …
Ratings
Current target
$7.55
Low
$13.00
High
$19.00
Mean
$15.14

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-28 main RBC Capital Outperform → Outperform $14
2026-04-28 reit Citizens Market Outperform → Market Outperform $19
2026-04-28 main Leerink Partners Outperform → Outperform $14
2026-04-27 main Needham Buy → Buy $15
2026-04-27 main D. Boral Capital Buy → Buy $14
2026-03-05 main Needham Buy → Buy $14
2026-02-11 main D. Boral Capital Buy → Buy $14
2026-01-23 main HC Wainwright & Co. Buy → Buy $13
2026-01-21 main RBC Capital Outperform → Outperform $13
2026-01-08 main D. Boral Capital Buy → Buy $14
2026-01-08 main Needham Buy → Buy $15
2025-12-18 main D. Boral Capital Buy → Buy $14
2025-11-13 main HC Wainwright & Co. Buy → Buy $18
2025-11-12 main D. Boral Capital Buy → Buy $14
2025-11-12 main Needham Buy → Buy $16
2025-10-21 main RBC Capital Outperform → Outperform $22
2025-10-20 up D. Boral Capital Hold → Buy $14
2025-09-09 reit JMP Securities Market Outperform → Market Outperform $22
2025-08-08 main HC Wainwright & Co. Buy → Buy $17
2025-06-30 down D. Boral Capital Buy → Hold —
News
RSS: Latest CRMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-04 TODISCO JOSEPH Chief Executive Officer — 77,156 $0.00 $0
2026-02-04 ZELNICK KAUFMAN BETH Officer — 36,006 $0.00 $0
2026-02-04 HURLBURT ELIZABETH Chief Operating Officer — 36,006 $0.00 $0
2026-01-26 LEFKOWITZ STEVEN W Director — 30,453 $0.00 $0
2026-01-26 DUNTON ALAN WILLIAM Director — 30,453 $0.00 $0
2026-01-26 STEWART ROBERT A Director — 30,453 $0.00 $0
2026-01-26 DILLIONE JANET M Director — 30,453 $0.00 $0
2026-01-26 KAPLAN MYRON Director — 30,453 $0.00 $0
2026-01-26 DUNCAN GREGORY SCOTT Director — 30,453 $0.00 $0
2026-01-23 TODISCO JOSEPH Chief Executive Officer — 225,900 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
311.71
+617.03%
43.47
0.00
-100.00%
0.07
Operating Revenue
311.71
+617.03%
43.47
0.00
-100.00%
0.07
Cost Of Revenue
35.96
+1027.30%
3.19
0.00
-100.00%
0.00
Reconciled Cost Of Revenue
35.96
+1027.30%
3.19
0.00
-100.00%
0.00
Gross Profit
275.75
+584.54%
40.28
0.00
-100.00%
0.06
Operating Expense
125.61
+100.53%
62.64
+27.94%
48.96
+59.55%
30.69
Research And Development
19.33
+390.44%
3.94
-70.03%
13.16
+23.18%
10.68
Selling General And Administration
106.27
+81.06%
58.70
+63.94%
35.80
+78.96%
20.01
Selling And Marketing Expense
38.05
+32.42%
28.74
+58.63%
18.12
—
General And Administrative Expense
68.22
+127.71%
29.96
+69.38%
17.69
—
Other Gand A
68.22
+127.71%
29.96
+69.38%
17.69
—
Total Expenses
161.57
+145.44%
65.83
+34.46%
48.96
+59.53%
30.69
Operating Income
150.14
+771.59%
-22.36
+54.34%
-48.96
-59.87%
-30.62
Total Operating Income As Reported
150.14
+771.59%
-22.36
+54.34%
-48.96
-59.87%
-30.62
EBITDA
167.35
+981.75%
-18.98
+58.95%
-46.23
-53.21%
-30.18
Normalized EBITDA
168.54
+989.47%
-18.95
+58.99%
-46.21
-52.93%
-30.21
Reconciled Depreciation
14.55
+4593.23%
0.31
+338.13%
0.07
-16.38%
0.08
EBIT
152.80
+892.15%
-19.29
+58.34%
-46.30
-53.02%
-30.26
Total Unusual Items
-1.19
-3735.48%
-0.03
-6.92%
-0.03
-178.06%
0.04
Total Unusual Items Excluding Goodwill
-1.19
-3735.48%
-0.03
-6.92%
-0.03
-178.06%
0.04
Special Income Charges
-6.50
0.00
—
—
Restructuring And Mergern Acquisition
6.50
0.00
—
—
Net Income
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Pretax Income
150.02
+876.28%
-19.32
+58.30%
-46.34
-53.00%
-30.29
Net Non Operating Interest Income Expense
1.06
-58.16%
2.54
-3.95%
2.65
+783.99%
0.30
Interest Expense Non Operating
2.78
+7627.78%
0.04
+4.97%
0.03
+29.35%
0.03
Net Interest Income
1.06
-58.16%
2.54
-3.95%
2.65
+783.99%
0.30
Interest Expense
2.78
+7627.78%
0.04
+4.97%
0.03
+29.35%
0.03
Interest Income Non Operating
3.85
+49.13%
2.58
-3.84%
2.68
+722.61%
0.33
Interest Income
3.85
+49.13%
2.58
-3.84%
2.68
+722.61%
0.33
Other Income Expense
-1.19
-343.65%
0.49
+1783.11%
-0.03
-178.06%
0.04
Other Non Operating Income Expenses
—
0.52
—
—
Gain On Sale Of Security
5.31
+17235.48%
-0.03
-6.92%
-0.03
-178.06%
0.04
Tax Provision
-13.04
-834.70%
-1.40
0.00
+100.00%
-0.59
Tax Rate For Calcs
0.00
+191.67%
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
-0.25
-11086.83%
-0.00
0.00
-100.00%
0.00
Net Income Including Noncontrolling Interests
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Net Income From Continuing Operation Net Minority Interest
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Net Income From Continuing And Discontinued Operation
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Net Income Continuous Operations
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Normalized Income
163.99
+1016.11%
-17.90
+61.34%
-46.31
-55.73%
-29.74
Net Income Common Stockholders
162.07
+1003.89%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Otherunder Preferred Stock Dividend
0.99
0.00
—
—
Diluted EPS
2.04
+780.00%
-0.30
+67.03%
-0.91
-22.97%
-0.74
Basic EPS
2.25
+850.00%
-0.30
+67.03%
-0.91
-22.97%
-0.74
Basic Average Shares
72.03
+22.36%
58.87
+15.65%
50.90
+26.39%
40.27
Diluted Average Shares
80.31
+36.41%
58.87
+15.65%
50.90
+26.39%
40.27
Diluted NI Availto Com Stockholders
162.07
+1003.89%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
826.14
+595.14%
118.85
+44.83%
82.06
+32.27%
62.04
Current Assets
367.05
+220.36%
114.58
+44.21%
79.45
+33.42%
59.55
Cash Cash Equivalents And Short Term Investments
148.53
+187.36%
51.69
-32.02%
76.03
+29.32%
58.79
Cash And Cash Equivalents
144.84
+256.29%
40.65
-6.85%
43.64
+1.15%
43.15
Other Short Term Investments
3.69
-66.53%
11.04
-65.92%
32.39
+107.03%
15.64
Receivables
171.23
+231.50%
51.65
0.00
0.00
Accounts Receivable
171.23
+231.50%
51.65
0.00
0.00
Gross Accounts Receivable
171.85
+231.81%
51.79
—
—
Allowance For Doubtful Accounts Receivable
-0.61
-348.91%
-0.14
—
—
Inventory
29.72
+291.00%
7.60
+260.81%
2.11
0.00
Raw Materials
3.63
+227.18%
1.11
-27.17%
1.53
0.00
Work In Process
11.69
+231.38%
3.53
+507.31%
0.58
0.00
Finished Goods
14.39
+385.98%
2.96
0.00
0.00
Prepaid Assets
9.05
+771.41%
1.04
+193.86%
0.35
+3109.64%
0.01
Restricted Cash
0.66
0.00
-100.00%
0.08
-37.59%
0.12
Other Current Assets
7.86
+203.05%
2.59
+194.03%
0.88
+41.45%
0.62
Total Non Current Assets
459.09
+10649.03%
4.27
+63.67%
2.61
+4.92%
2.49
Net PPE
8.98
+286.69%
2.32
-7.36%
2.51
+5.10%
2.38
Gross PPE
8.98
+286.69%
2.32
-23.30%
3.03
+6.81%
2.83
Accumulated Depreciation
—
-0.67
-29.37%
-0.52
-15.83%
-0.45
Other Properties
8.98
+286.69%
2.32
-23.30%
3.03
+6.81%
2.83
Goodwill And Other Intangible Assets
409.07
+22084.06%
1.84
0.00
—
Goodwill
30.00
0.00
—
—
Other Intangible Assets
379.07
+20457.05%
1.84
—
—
Investments And Advances
10.36
0.00
—
—
Non Current Accounts Receivable
0.95
—
—
—
Non Current Deferred Assets
16.28
0.00
—
—
Non Current Deferred Taxes Assets
16.28
0.00
—
—
Non Current Prepaid Assets
13.03
0.00
—
—
Other Non Current Assets
0.42
+302.86%
0.10
+1.89%
0.10
+0.72%
0.10
Total Liabilities Net Minority Interest
420.83
+1130.91%
34.19
+186.88%
11.92
+70.77%
6.98
Current Liabilities
174.27
+414.98%
33.84
+196.83%
11.40
+80.65%
6.31
Payables And Accrued Expenses
169.81
+404.29%
33.67
+199.31%
11.25
+82.15%
6.18
Payables
21.45
+476.51%
3.72
-13.08%
4.28
+94.34%
2.20
Accounts Payable
7.88
+358.37%
1.72
-59.81%
4.28
+94.34%
2.20
Other Payable
0.80
-59.80%
2.00
—
—
Current Accrued Expenses
148.36
+395.32%
29.95
+329.71%
6.97
+75.40%
3.97
Total Tax Payable
12.76
0.00
—
—
Income Tax Payable
12.76
0.00
—
—
Current Debt And Capital Lease Obligation
1.45
+762.50%
0.17
+11.54%
0.15
+11.73%
0.13
Current Capital Lease Obligation
1.45
+762.50%
0.17
+11.54%
0.15
+11.73%
0.13
Other Current Liabilities
3.02
—
—
—
Total Non Current Liabilities Net Minority Interest
246.57
+70549.28%
0.35
-32.50%
0.52
-22.56%
0.67
Long Term Debt And Capital Lease Obligation
147.47
+42153.58%
0.35
-32.50%
0.52
-22.56%
0.67
Long Term Debt
144.63
—
—
—
Long Term Capital Lease Obligation
2.84
+713.47%
0.35
-32.50%
0.52
-22.56%
0.67
Other Non Current Liabilities
99.10
—
—
—
Stockholders Equity
405.31
+378.76%
84.66
+20.69%
70.14
+27.39%
55.06
Common Stock Equity
405.31
+378.76%
84.66
+20.69%
70.14
+27.39%
55.06
Capital Stock
0.08
+23.44%
0.06
+16.11%
0.06
+28.19%
0.04
Common Stock
0.08
+23.44%
0.06
+16.49%
0.05
+28.31%
0.04
Preferred Stock
0.00
0.00
-100.00%
0.00
+0.00%
0.00
Share Issued
79.26
+23.05%
64.41
+17.24%
54.94
+28.31%
42.82
Ordinary Shares Number
79.26
+23.05%
64.41
+17.24%
54.94
+28.31%
42.82
Additional Paid In Capital
581.80
+37.17%
424.13
+8.28%
391.69
+18.59%
330.29
Retained Earnings
-176.57
+48.01%
-339.63
-5.57%
-321.70
-16.83%
-275.36
Gains Losses Not Affecting Retained Earnings
0.00
-96.70%
0.09
-3.30%
0.09
+13.74%
0.08
Other Equity Adjustments
0.00
-96.70%
0.09
-3.30%
0.09
+13.74%
0.08
Total Equity Gross Minority Interest
405.31
+378.76%
84.66
+20.69%
70.14
+27.39%
55.06
Total Capitalization
549.93
+549.60%
84.66
+20.69%
70.14
+27.39%
55.06
Working Capital
192.78
+138.78%
80.73
+18.64%
68.05
+27.82%
53.24
Invested Capital
549.93
+549.60%
84.66
+20.69%
70.14
+27.39%
55.06
Total Debt
148.91
+28703.48%
0.52
-22.56%
0.67
-16.80%
0.80
Capital Lease Obligations
4.29
+729.40%
0.52
-22.56%
0.67
-16.80%
0.80
Net Tangible Assets
-3.77
-104.55%
82.81
+18.06%
70.14
+27.39%
55.06
Tangible Book Value
-3.77
-104.55%
82.81
+18.06%
70.14
+27.39%
55.06
Available For Sale Securities
10.36
—
—
—
Interest Payable
2.33
0.00
—
—
Investmentin Financial Assets
10.36
0.00
—
—
Preferred Shares Number
0.04
+0.00%
0.04
-50.00%
0.09
+0.00%
0.09
Preferred Stock Equity
—
0.00
-24.73%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
175.05
+445.84%
-50.62
-31.78%
-38.41
-57.70%
-24.36
Cash Flow From Continuing Operating Activities
175.05
+445.84%
-50.62
-31.78%
-38.41
-57.70%
-24.36
Net Income From Continuing Operations
163.06
+1009.40%
-17.93
+61.31%
-46.34
-56.02%
-29.70
Depreciation Amortization Depletion
14.55
+4593.23%
0.31
+338.13%
0.07
-16.38%
0.08
Depreciation
0.68
+339.61%
0.15
+117.65%
0.07
-16.38%
0.08
Amortization Cash Flow
13.87
+8792.31%
0.16
0.00
—
Depreciation And Amortization
14.55
+4593.23%
0.31
+338.13%
0.07
-16.38%
0.08
Amortization Of Intangibles
13.87
+8792.31%
0.16
0.00
—
Other Non Cash Items
7.28
+4816.22%
0.15
+9.79%
0.13
+8.35%
0.12
Stock Based Compensation
13.83
+125.68%
6.13
+11.56%
5.49
+35.00%
4.07
Provisionand Write Offof Assets
0.25
+83.94%
0.14
0.00
—
Deferred Tax
-25.80
0.00
—
—
Deferred Income Tax
-25.80
0.00
—
—
Operating Gains Losses
-0.09
—
—
—
Unrealized Gain Loss On Investment Securities
-5.36
0.00
—
—
Change In Working Capital
7.33
+118.60%
-39.41
-1866.88%
2.23
+109.15%
1.07
Change In Receivables
-90.92
-75.56%
-51.79
0.00
-100.00%
0.04
Changes In Account Receivables
-90.92
-75.56%
-51.79
0.00
-100.00%
0.04
Change In Inventory
-3.48
+36.68%
-5.49
-160.78%
-2.11
-70124.77%
0.00
Change In Prepaid Assets
-2.06
+14.09%
-2.40
-299.18%
-0.60
-420.98%
0.19
Change In Payables And Accrued Expense
104.10
+409.67%
20.43
+302.66%
5.07
+430.94%
0.96
Change In Accrued Expense
100.77
+338.42%
22.98
+667.42%
3.00
+211.35%
0.96
Change In Payable
3.33
+230.04%
-2.56
-223.23%
2.08
+31739.95%
-0.01
Change In Account Payable
3.33
+230.04%
-2.56
-223.23%
2.08
+31739.95%
-0.01
Change In Other Current Liabilities
-0.31
-103.97%
-0.15
-12.02%
-0.13
-11.07%
-0.12
Investing Cash Flow
-308.43
-1552.73%
21.23
+224.44%
-17.06
-359.96%
-3.71
Cash Flow From Continuing Investing Activities
-308.43
-1552.73%
21.23
+224.44%
-17.06
-359.96%
-3.71
Net PPE Purchase And Sale
-2.26
-1848.28%
-0.12
+64.56%
-0.33
-49.21%
-0.22
Purchase Of PPE
-2.26
-1848.28%
-0.12
+64.56%
-0.33
-49.21%
-0.22
Capital Expenditure
-2.26
-1848.28%
-0.12
+64.56%
-0.33
-49.21%
-0.22
Net Investment Purchase And Sale
2.34
-89.03%
21.35
+227.56%
-16.73
-379.49%
-3.49
Purchase Of Investment
-52.95
-97.81%
-26.77
+65.27%
-77.08
-147.54%
-31.14
Sale Of Investment
55.29
+14.92%
48.12
-20.27%
60.35
+118.26%
27.65
Net Business Purchase And Sale
-308.51
0.00
—
—
Purchase Of Business
-308.51
0.00
—
—
Gain Loss On Sale Of Business
-0.09
0.00
—
—
Financing Cash Flow
238.45
+806.01%
26.32
-52.93%
55.92
+212.42%
17.90
Cash Flow From Continuing Financing Activities
238.45
+806.01%
26.32
-52.93%
55.92
+212.42%
17.90
Net Issuance Payments Of Debt
150.00
0.00
—
—
Issuance Of Debt
150.00
0.00
—
—
Long Term Debt Issuance
150.00
0.00
—
—
Net Long Term Debt Issuance
150.00
0.00
—
—
Net Common Stock Issuance
90.16
+377.48%
18.88
-66.18%
55.83
+214.17%
17.77
Proceeds From Stock Option Exercised
6.39
-17.32%
7.73
+2585.43%
0.29
+123.70%
0.13
Net Other Financing Charges
-8.09
-2691.03%
-0.29
-46.14%
-0.20
—
Changes In Cash
105.07
+3528.03%
-3.06
-787.78%
0.45
+104.38%
-10.17
Effect Of Exchange Rate Changes
0.00
+100.00%
-0.00
-171.23%
0.00
+132.36%
-0.01
Beginning Cash Position
40.76
-7.00%
43.82
+1.03%
43.37
-19.00%
53.55
End Cash Position
145.82
+257.80%
40.76
-7.00%
43.82
+1.03%
43.37
Free Cash Flow
172.79
+440.59%
-50.73
-30.96%
-38.74
-57.62%
-24.58
Interest Paid Supplemental Data
0.02
-52.78%
0.04
+4.97%
0.03
+29.34%
0.03
Common Stock Issuance
90.16
+377.48%
18.88
-66.18%
55.83
+214.17%
17.77
Issuance Of Capital Stock
90.16
+377.48%
18.88
-66.18%
55.83
+214.17%
17.77
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category